AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$392M |
| 2 |
Qualcomm
QCOM
|
+$262M |
| 3 |
Microsoft
MSFT
|
+$260M |
| 4 |
Illumina
ILMN
|
+$259M |
| 5 |
International Flavors & Fragrances
IFF
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$341M |
| 2 |
Biogen
BIIB
|
+$295M |
| 3 |
Apple
AAPL
|
+$289M |
| 4 |
Booking.com
BKNG
|
+$207M |
| 5 |
CELG
Celgene Corp
CELG
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 15.41% |
| 3 | Financials | 15.33% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Nordic American Tanker
NAT
$1.37B
| $779K | ﹤0.01% |
158,355
| – | – |
|
2377
Akebia Therapeutics
AKBA
$343M
| $776K | ﹤0.01% |
122,819
| – | – |
|
2378
Kinross Gold
KGC
$28.6B
| $776K | ﹤0.01% |
163,621
-1,739
| -1% | -$7.85K |
|
|
KDMN
2379
DELISTED
Kadmon Holdings, Inc.
KDMN
| $776K | ﹤0.01% |
171,400
+49,700
| +41% | +$182K |
|
2380
Evolent Health
EVH
$429M
| $772K | ﹤0.01% |
85,300
-38
| -0% | -$309 |
|
2381
LeMaitre Vascular
LMAT
$2.26B
| $771K | ﹤0.01% |
21,450
+100
| +0.5% | +$3.45K |
|
2382
Liberty Energy
LBRT
$2.75B
| $764K | ﹤0.01% |
68,700
| – | – |
|
2383
Opko Health
OPK
$936M
| $761K | ﹤0.01% |
517,625
+11,600
| +2% | +$19.4K |
|
|
CRCM
2384
DELISTED
CARE.COM, INC.
CRCM
| $761K | ﹤0.01% |
50,650
+22,850
| +82% | +$274K |
|
|
BNFT
2385
DELISTED
Benefitfocus, Inc.
BNFT
| $760K | ﹤0.01% |
34,630
| – | – |
|
|
TEN
2386
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $760K | ﹤0.01% |
58,020
| – | – |
|
|
TWOU
2387
DELISTED
2U Inc
TWOU
| $757K | ﹤0.01% |
1,051
+56
| +6% | +$34.8K |
|
|
RESI
2388
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $756K | ﹤0.01% |
61,239
-5,640
| -8% | -$67K |
|
|
SIEN
2389
DELISTED
Sientra, Inc.
SIEN
| $755K | ﹤0.01% |
8,440
| – | – |
|
2390
Customers Bancorp
CUBI
$2.66B
| $754K | ﹤0.01% |
31,650
+200
| +0.6% | +$4.59K |
|
2391
AdvanSix
ASIX
$546M
| $752K | ﹤0.01% |
37,669
-4,200
| -10% | -$91.8K |
|
2392
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
| $750K | ﹤0.01% |
+24,360
| New | +$751K |
|
|
GLDD
2393
DELISTED
Great Lakes Dredge & Dock
GLDD
| $748K | ﹤0.01% |
66,000
| – | – |
|
2394
CEVA Inc
CEVA
$980M
| $744K | ﹤0.01% |
27,610
+160
| +0.6% | +$4.37K |
|
|
SRDX
2395
DELISTED
Surmodics
SRDX
| $742K | ﹤0.01% |
17,921
+100
| +0.6% | +$4.21K |
|
|
PENG
2396
Penguin Solutions Inc
PENG
$2.69B
| $742K | ﹤0.01% |
39,100
-17,000
| -30% | -$263K |
|
|
I
2397
DELISTED
INTELSAT S. A.
I
| $742K | ﹤0.01% |
105,600
-96,604
| -48% | -$1.52M |
|
2398
Ecovyst
ECVT
$1.34B
| $740K | ﹤0.01% |
43,100
-1,600
| -4% | -$25.7K |
|
|
CLVS
2399
DELISTED
Clovis Oncology, Inc.
CLVS
| $740K | ﹤0.01% |
71,000
-12,140
| -15% | -$88.3K |
|
2400
Cytokinetics
CYTK
$10.9B
| $739K | ﹤0.01% |
69,650
+2,550
| +4% | +$26.2K |
|
Similar funds
AllianceBernstein's Q4 2019 Portfolio in Review
As of Q4 2019, AllianceBernstein held 3,209 positions worth $176B, up 9.6% from $161B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.6%. AllianceBernstein opened 57 new positions and exited 91, leaving the 3,209-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2019 buy was Tradeweb Markets: 1,191,306 shares worth $55.2M.
- AllianceBernstein added most to Nike in Q4 2019, an estimated $392M increase.
- AllianceBernstein's biggest Q4 2019 reduction was JPMorgan Chase, cutting an estimated $341M.
- AllianceBernstein fully exited Celgene Corp in Q4 2019, selling an estimated $194M.
- AllianceBernstein's ten largest holdings make up 19% of its $176B portfolio in Q4 2019.
- AllianceBernstein opened 57 new positions and closed 91 in Q4 2019.
- AllianceBernstein's portfolio value rose 9.6% quarter-over-quarter to $176B.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.